Details of the Drug-Related molecule(s) Expression Atlas
General Information of Drug (ID: DMQ3LMF)
Drug Name | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
111947-24-1; ethyl 4-{[(2-oxo-2H-chromen-3-yl)carbonyl]amino}benzoate; AC1LHTSN; CBMicro_028869; 3-carboxamido coumarin, 15; Oprea1_481544; ethyl 4-(2-oxo-2H-chromene-3-carboxamido)benzoate; CHEMBL470419; BDBM29165; MolPort-000-375-263; MISJYZJMFQOBPG-UHFFFAOYSA-N; ZINC434162; STK401564; AKOS001279407; MCULE-7936571021; LS-38062; BIM-0028988.P001; ST4083371; ethyl 4-(2-oxo-2H-chromene-3-amido)benzoate; ethyl 4-[(2-oxochromen-3-yl)carbonylamino]benzoate; ethyl 4-[(2-oxochromene-3-carbonyl)amino]benzoate; Z30248586; F1006-0090
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecule(s) Related to This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs
|
||||||||||||||||||||||||||
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs | ||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue | ||||||||||||||||||||||||